A Study to Assess the Effect of My Happy Flo on Alleviating Period Symptoms and Heavy Flows.
1 other identifier
interventional
40
1 country
1
Brief Summary
This clinical study aims to evaluate the effectiveness of My Happy Flo, a dietary supplement, in alleviating period symptoms and heavy menstrual flows. The study involves 40 participants, who will take the supplement daily for three menstrual cycles. Primary outcomes, such as the severity of heavy flows, prolonged periods, cramps, mood, energy levels, cycle regulation, and fatigue, will be measured using validated questionnaires completed after each menstrual cycle. Secondary outcomes, including Vitamin D and Iron levels, will be assessed through blood tests at the beginning and end of the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2024
CompletedFirst Submitted
Initial submission to the registry
July 17, 2024
CompletedFirst Posted
Study publicly available on registry
July 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedNovember 20, 2024
November 1, 2024
3 months
July 17, 2024
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in Period Symptoms
Measurement of heavy flows, prolonged periods, cramps, mood disturbances, energy levels, cycle regulation, and fatigue using validated questionnaires.
Baseline (Day 0), Cycle 1, Cycle 2, and Cycle 3 - each Cycle is 28 days
Secondary Outcomes (2)
Changes in Vitamin D Level
Baseline and Cycle 3 - each Cycle is 28 days
Changes in Iron Level
Baseline and Cycle 3 - each Cycle is 28 days
Study Arms (1)
My Happy Flo Supplement
EXPERIMENTALParticipants will take two capsules of My Happy Flo daily, preferably in the morning with 8-10 oz of water and a meal, for three menstrual cycles.
Interventions
The intervention aims to alleviate period symptoms including heavy flows, prolonged periods, cramps, mood disturbances, energy levels, cycle regulation, and fatigue. Blood tests for Vitamin D and Iron levels will be conducted at Baseline and after the third menstrual cycle. Participants will complete validated questionnaires assessing period symptoms after each menstrual cycle.
Eligibility Criteria
You may qualify if:
- Female, aged 18 or over
- Experiencing heavy period flows
- Two or more self-reported symptoms (prolonged periods, cramps, poor mood, fatigue, irregular cycle)
- Signs of potential anemia or iron deficiency
- No known allergies to the product ingredients
- Willing to comply with study requirements and limit caffeine intake
- Generally healthy - do not live with any uncontrolled chronic disease
You may not qualify if:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- A diagnosis of sports anemia within the previous 6 months
- Anyone with known severe allergic reactions that require an Epi-Pen
- Women who are pregnant, breastfeeding, or trying to conceive
- Anyone unwilling to follow the study protocol
- Anyone who has undergone any surgeries or invasive treatments (such as immunotherapy, chemotherapy, radiation, or biological cancer) in the last 30 days or has any planned for the next 12 weeks
- Anyone with a history of substance abuse
- Anyone currently participating or planning to participate in a research study
- Anyone taking prescription anticonvulsants (anti-seizure medications)
- Anyone taking prescription anticoagulant medications (blood thinners)
- Anyone taking any hormone-modulating medications (e.g., hormonal birth control, hormone replacement therapy, testosterone, tamoxifen, thyroid medications, etc.)
- History of hysterectomy, oophorectomy, or other surgery to the reproductive organs
- History of gynecologic cancer, such as cervical, ovarian, uterine, vaginal, or vulvar cancer
- Currently experiencing menopausal or perimenopausal symptoms
- Changes or cessation of hormonal birth control in the last three months
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- My Happy Flolead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Santa Monica, California, 90404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2024
First Posted
July 26, 2024
Study Start
May 31, 2024
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
November 20, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share